Foundation and Legislative Supporters Pushed for Bill
WASHINGTON, April 29 /PRNewswire-USNewswire/ -- The Cystic Fibrosis
Foundation praised the U.S. Senate for officially recognizing May as
National Cystic Fibrosis Awareness Month and encouraging public awareness
and understanding of CF.
Introduced by Senators Patty Murray (D-Wash.) and Jim Inhofe (R-Okla.),
the legislation calls attention to cystic fibrosis, a fatal, genetic
disease, and supports research to find a cure.
"We are thrilled to have the Senate's support for our mission to find a
cure for cystic fibrosis. We are making dramatic progress in the
development of new therapies for the disease and in extending life
expectancy," said Robert J. Beall, Ph.D., president and CEO of the
Foundation. "On behalf of all those affected by CF, we thank Senators
Murray and Inhofe for their leadership and commitment to the cystic
fibrosis community."
Cystic fibrosis affects 30,000 children and adults in the United States
and 70,000 people worldwide. When the Cystic Fibrosis Foundation was
created in 1955, few children lived to attend elementary school. Today, as
a result of dramatic improvements in research and care fueled by the
Foundation, the median age of survival for a person with CF has risen to
age 37 -- double what it was 25 years ago.
The Foundation has built a "pipeline of promise" with more than 30
therapies in development for cystic fibrosis. For the first time in the
history of the disease, this pipeline has drugs under development that
target the root cause of cystic fibrosis. If successful, these therapies
will add decades of life for people with CF.
Virtually every approved CF drug available today was made possible
because of Foundation support. Since the 1980s, the Foundation has played
an integral role in the development of Pulmozyme, TOBI, azithromycin and
hypertonic saline for use as CF treatments.
About the Cystic Fibrosis Foundation
The Cystic Fibrosis Foundation is the leading organization in the
United States devoted to curing and controlling cystic fibrosis.
Headquartered in Bethesda, Md., the Foundation has more than 80 chapters
and branch offices throughout the country and supports and accredits a
nationwide network of more than 115 care centers. To advance the search for
a cure, the Foundation has invested nearly $300 million in promising drug
research in the biotech industry since 1998. For more information, visit
http://www.cff.org.
See Also
- Health Insurance Types – Cafeteria Plan
- IshopPlusSize.com Launches Just Days Before Mother’s Day to Offer Fashion Styles for Plus-Size Divas
- What Type Of Topical Solution For Hair Loss Will Suit You?
- Amateur Golfer hits 4 Hole-in-Ones During Million Dollar Shootout Including 2 Back to Back
Via: Healthcare
0 коментарі:
Post a Comment